Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
R. Timmerman,Chen Hu,12 Autori,H. Choy
2014 · DOI: 10.1016/J.IJROBP.2014.05.135
204 citazioni
TLDR
This validated model demonstrates that operability, tumor diameter, PTV size, BED10 and age form the basis of a new risk stratification for OS in stage I NSCLC patients treated with SABR that may help define subgroups for future clinical trials.